DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, announced today it will be holding a business update conference call on Thursday, January 3, 2008, with the investment community at 11:30AM ET. During the conference call, Neoprobe’s President and CEO, David Bupp, will discuss the Company’s recently completed $13 million financing transaction with Platinum-Montaur Life Sciences LLC, the status of Lymphoseek product development activities as well as other recent events at the Company. The conference call can be accessed as follows:
